$134.42−$0.13 (-0.10%)as of market close, Aug 13, 2026
☾ After hours:$134.45+0.00%3:59 PM ET
APGE — Apogee Therapeutics Inc. stock price, chart and key statistics
Key stats#
Price data
- Price
- $134.42
- Change YTD
- +78.09%
- Market cap
- 10.2B
- Enterprise value
- 9.2B
- Shares outstanding
- 75.7M
- 52W low
- $35.39
- 52W high
- $134.88
- From 52W high
- -0.34%
- From 52W low
- +279.82%
- 52W range
- 100%
- Beta
- 0.29
Volume
- Rel volume
- 0.75×
- 30D volume
- 1.3M
- 30D $ vol
- 171.7M
Fundamentals
- EPS (ttm)
- -$4.34
- FCF (ttm)
- -232.6M
- FCF/share
- $-3.07
- ROA
- -22.04%
- Current ratio
- 26.44
Growth (CAGR, ttm) · 10Y
- Net income
- n/a
- FCF
- n/a
- Shares
- n/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a
- FCF/share
- n/a
- Price
- n/a
- Total return
- n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- Fwd P/E
- -25.9×
- -2.29%
- -3.71%
- -3.71%
Performance · price return#
1D
-0.10%
1W
-0.05%
1M
+0.10%
3M
+60.14%
YTD
+78.09%
1Y
+266.27%
5Y
n/a
Financial statements
Open full APGE financials →Related Health Care#
1MApogee Therapeutics Inc. (APGE) trades at $134.42 with a live price and an interactive chart covering 3+ years of daily price history, plus key valuation metrics. ChartRow also publishes APGE's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full APGE financial statements →